Are you confident in your ability to ensure your Gross-to-Net calculations are accurate?
Does your company manage its commercial and government contracts as efficiently as possible?
Are you able to facilitate inter-departmental collaboration for a comprehensive approach to your calculations?
IIR’s Gross-to-Net Accounting Forum for Pharmaceutical Manufacturers answers all these questions and more, with in-depth case studies and important GTN procedural information to help you optimize the accuracy and accountability of your pharmaceutical GTN process. Both government and commercial departmental collaboration is emphasized with content covering both sides of GTN calculations. This unique event is the only one to bring branded and generic manufacturers, large and small pharma, and commercial and government departments together for the 360 GTN perspective. Interactive sessions bring you into the content, ensuring you and your peers learn best practices and return to the office better equipped to manage your GTN data.
Session highlights include:
- Properly Forecast for New Product Launches to Decrease Return Reserves
- Using Analytics Beyond Excel to More Easily Pull Together GTN Data
- Identifying and Anticipating Changing Managed Care Rebates Moving into 2014
- Process Evaluation for Small to Mid-Sized Pharmaceutical Companies
Gross-to-Net Accounting Forum for Pharmaceutical Manufacturers
June 17-18, 2013
Hyatt Harbor Side, Boston, MA
Register by March 22nd and save $400 off the standard registration rate. Visit the website or call (888) 670-8200 to register. Be sure to use priority code XP1811MNT1 when registering.
Institute for International Research